Canada markets open in 6 hours 47 minutes

AbbVie Inc. (ABBV)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
131.98-1.05 (-0.79%)
At close: 04:02PM EST
131.63 -0.35 (-0.27%)
After hours: 07:58PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close133.03
Bid0.00 x 800
Ask0.00 x 800
Day's Range131.67 - 134.25
52 Week Range101.81 - 138.15
Avg. Volume6,574,448
Market Cap233.325B
Beta (5Y Monthly)0.82
PE Ratio (TTM)31.45
EPS (TTM)4.20
Earnings DateFeb. 02, 2022
Forward Dividend & Yield5.64 (4.27%)
Ex-Dividend DateJan. 13, 2022
1y Target Est139.71
  • Motley Fool

    Is AbbVie Stock a Top Pick for 2022?

    Treasury yields are rising, and the Federal Reserve is expected to raise interest rates multiple times in 2022. In the case of AbbVie (NYSE: ABBV), look no further. AbbVie is a global prescription drug developer, manufacturer, and distributor that was spun off from parent company Abbott Labs back in 2013.

  • Motley Fool

    3 Clinical Trials to Watch in the First Half of 2022

    In this Motley Fool Live video recorded on Jan. 12, 2022, Fool contributors Keith Speights and Brian Orelli discuss three clinical trials especially worth watching in the first half of 2022. Which clinical results are you especially looking forward to seeing? Brian Orelli: Arena (NASDAQ: ARNA), the ticker there is A-R-N-A, it expects data from a phase 3 study of etrasimod in patients with ulcerative colitis.

  • Zacks

    Pharma Stock Roundup: GSK's Consumer Unit Offer Rejection, FDA Updates for AZN, PFE

    Glaxo (GSK) rejects a $68 billion buyout offer for its consumer healthcare unit from Unilever. FDA updates for Pfizer (PFE), AbbVie (ABBV) and AstraZeneca (AZN) grab headlines.